Company: MIRM
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001759425-25-000054
Chunk: 334

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part II, Item 2
Chunk 334
---
 Report on Form 10-Q), unless the Registrant specifically incorporates the foregoing information into those documents by reference.

91

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Mirum Pharmaceuticals, Inc.  Date: November 4, 2025By:/s/ Christopher Peetz Christopher Peetz Chief Executive Officer(Principal Executive Officer)  Mirum Pharmaceuticals, Inc.  Date: November 4, 2025By:/s/ Eric Bjerkholt Eric Bjerkholt Chief Financial Officer(Principal Financial Officer)

92